Prostate Cancer Archives - Cancer Therapy Advisor

Prostate Cancer Surgery Lagged for Black Men During Pandemic

July 29, 2021

Black men less likely than White men to undergo prostatectomy despite similar COVID-19 risk factors, biopsy Gleason grade groups.

The FDA’s accelerated approval of the PARP inhibitor rucaparib brings clinical prostate oncology into the precision medicine era.

Prostate Cancer

Ipatasertib Plus Abiraterone: A New Potential Treatment for Metastatic Castration-Resistant Prostate Cancer With PTEN Loss

By

Sucharita Mistry, PhD

July 26, 2021

The combination improved progression-free survival.

Many clinical and ethical factors influence whether preemptive transplant would be beneficial for patients genetically predisposed to acute myeloid leukemia.

Prostate Cancer

Nomograms May Aid Patient Selection for 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer

By

Leah Lawrence

July 23, 2021

The nomograms predicted overall and progression-free survival.

Radiologist consoling a senior patient at MRI scan.

Prostate Cancer

MRI Can Avoid Unnecessary Prostate Biopsies Among Screened Men

By

Natasha Persaud

July 20, 2021

In a trial of men who volunteered for PSA screening, detection of clinically insignificant tumors and benign findings were reduced when prostate biopsy was performed only in those with positive MRI results.

Prostate Cancer

Mortality Risk Factors in Patients With Cancer and COVID-19 Identified

By

Jody A. Charnow

July 19, 2021

Investigators zero in on mortality risk factors in patients with cancer who contract COVID-19.

Prostate Cancer

Pathologic Outcomes in Prostate Cancer Cases Worsened During Pandemic

By

Jody A. Charnow

July 17, 2021

Compared with before the pandemic, men undergoing radical prostatectomy during the pandemic were more likely to have extraprostatic disease, according to investigators.

Prostate Cancer

PSMA-PET/CT May Detect Prostate Cancer More Accurately Than mpMRI

By

Natasha Persaud

July 17, 2021

Early results support a fully-powered trial of 18F-PSMA PET/CT for prostate cancer detection, according to the investigators.

Prostate Cancer

Apalutamide Prolongs Survival in mCSPC Regardless of Disease Volume

By

Jody A. Charnow

July 16, 2021

A final analysis of the TITAN trial shows that apalutamide vs placebo added to ADT significantly lowers the risk of death and castration-resistant disease in men with metastatic castration-sensitive prostate cancer.

Prostate Cancer

Obesity Linked to Lower Death Risk in mCRPC

By

Jody A. Charnow

July 15, 2021

Obesity in men with metastatic castration-resistant prostate cancer is associated with decreased risks for all-cause and cancer-specific mortality compared with overweight and normal-weight men.

Multiparametric MRI images (coronal view) demonstrating PIRADS 5 signal abnormality in the right peripheral zone of the prostate. A PIRADS 4 lesion can also be seen in the right transitional zone.

Prostate Cancer

mpMRI Misses Few Significant Prostate Cancers in Re-Biopsied Men

By

Natasha Persaud

July 14, 2021

Study findings lend support to using mpMRI for prostate cancer detection.